Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
CASI CASI Pharmaceuticals
- 2.5000
- -0.0900-3.47%
Close Feb 14 16:00 ET
- 2.5000
- 0.00000.00%
Post 20:01 ET
38.73MMarket Cap-1.12P/E (TTM)
2.6500High2.4800Low19.89KVolume2.6200Open2.5900Pre Close50.71KTurnover0.25%Turnover RatioLossP/E (Static)15.49MShares7.670052wk High2.80P/B19.66MFloat Cap2.050052wk Low--Dividend TTM7.87MShs Float11137.4899Historical High--Div YieldTTM6.56%Amplitude1.4500Historical Low2.5500Avg Price1Lot Size
About CASI Pharmaceuticals Company
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing innovative therapeutics and pharmaceutical products. The firm is also involved in developing innovative therapeutics addressing cancer and other unmet medical needs for the global market. The company was founded in 1991 and is headquartered in Beijing, China.
Company Profile
SymbolCASI
Company NameCASI Pharmaceuticals
Listing DateJun 12, 1996
Issue Price15.00
Founded1991
CEODr. Wei-Wu He
MarketNASDAQ
Employees243
Fiscal Year Ends12-31
Address1701-1702, China Central Office,Tower 1, No. 81 Jianguo Road,Chaoyang District
CityBeijing
ProvinceBeijing
CountryChina
Zip Code100025
Phone86-10-6508-6063
Company Executives
- Name
- Position
- Salary
- Dr. Wei-Wu He
- Chairman of the Board and Chief Executive Officer
- --
- Chunhua Wang
- Chief Operation Officer
- --
- Hai Huang
- Executive Vice President and Global Chief Commercial Officer
- --
- Dr. Alexander A. Zukiwski
- Executive Vice President and Global Chief Medical Officer
- --
- Wei Zhang
- President and Principal Financial Officer
- --
- Kun Qian
- Global Controller and Vice President
- --
- Dr. Y. Alexander Wu
- Independent Director
- --
- Xuebo Zeng
- Independent Director
- --
- Zhenbo Su
- Independent Director
- --
- Thomas Folinsbee
- Independent Director
- --
- Wei Gao
- General Counsel
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.